Sidley represented IO Biotech (Nasdaq: IOBT) in connection with its US$115.1 million initial public offering of common stock on The Nasdaq Global Market. IO Biotech sold 8,222,500 shares of its common stock, including the exercise in full by the underwriters’ option to purchase 1,072,500 additional shares of common stock, at the IPO price of US$14.00 per share. Continue reading 

See all Member News